Nature of Business - Additional Information (Detail) - USD ($) |
3 Months Ended | 9 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Nature Of Operations [Line Items] | |||||||||
| Retained earnings (accumulated deficit) | $ 291,610,000 | $ 291,610,000 | $ 222,737,000 | ||||||
| Net loss | $ (21,347,000) | $ (22,285,000) | $ (25,241,000) | $ (19,035,000) | $ (19,984,000) | $ (15,906,000) | $ (68,873,000) | $ (54,925,000) | |
| Sale of stock issue price per share | $ 33.05 | $ 33.05 | |||||||
| Proceeds from Issuance or Sale of Equity, Total | $ 400,000,000 | ||||||||
| Cash and cash equivalents | $ 234,666,000 | $ 268,435,000 | 234,666,000 | $ 268,435,000 | $ 253,798,000 | ||||
| ATM | |||||||||
| Nature Of Operations [Line Items] | |||||||||
| Sale of Stock, Consideration Received after deducting expenses, Net | 22,300,000 | 35,400,000 | |||||||
| Commissions and offering expenses | $ 400 | $ 700,000 | |||||||
| Sale of stock issue price per share | $ 34.45 | $ 34.45 | |||||||
| Aggregate consideration | $ 22,700,000 | $ 36,100,000 | |||||||
| Proceeds from the issuance of common stock | $ 100,000,000 | ||||||||
| Sale of Stock, Number of Shares Issued in Transaction | 660,492 | 1,092,798 | |||||||
| X | ||||||||||
- Definition Nature of operations. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for cost associated with issuance of security by investment company. Includes, but is not limited to, legal fee pertaining to share offered for sale, registration fee, underwriting, printing prospectus, and initial fee for listing on exchange. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|